Neuropresse is a groundbreaking platform aiming to address the stigma surrounding mental health. Founded in 2017, the startup serves as an integrative space for individuals with psychological disorders to share their experiences and for the general population to gain insights into these disorders and the latest advancements in research. The platform's objectives include providing a platform for affected individuals to express themselves, connecting those facing similar challenges, raising awareness about mental illness, and disseminating recent scientific developments. The company's mission is to integrate mental health and neuroscience into the public consciousness to challenge misconceptions and reduce stigma. Neuropresse operates at the intersection of Health and Wellness and Publishing, with a focus on reshaping societal perceptions of mental health. Currently, there is no information available on their headquarter location, recent investment amounts, or investors. Nevertheless, the innovative and socially impactful nature of Neuropresse positions it as a significant player in the mental health and wellness space.
There is no investment information
No recent news or press coverage available for Neuropresse.